IP Library Granted Patent US 6,921,414
Granted Patent B2
US 6,921,414 · App. 10/308,574 · Granted Jul 26, 2005

Endoluminal prosthesis and tissue separation condition treatment method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,921,414
App. No.
10/308,574
Granted
Jul 26, 2005
Kind
B2
Abstract

An endoluminal prosthesis includes a coiled body and a graft material covering at least part of the coiled body to create a coiled stent graft. The average stent graft diameter to turns width ratio may be about 0.8 to 1 to about 2.4 to 1 when expanded.

Claims (9)

1. A vascular dissection-treating endoluminal prosthesis comprising:

a coiled, generally helically extending body;

a graft material covering the entire coiled body to create a coiled stent graft movable between radially expanded and radially contracted conditions;

the coiled body comprising laterally spaced-apart, longitudinally extending rail elements and transversely extending connector elements connecting the rail elements;

said coiled stent graft having generally helically extending turns with first and second generally helically extending edges and a width measured perpendicular to said edges, said stent graft placeable in the radially contracted condition for placement and in the radially expanded condition for use; and

said stent graft, when in the radially expanded condition, constructed to have at most 2 turns and to press outwardly against a wall within an aortic arch of a patient so to force any separated intimal lining back against a remainder of the wall.

2. The endoluminal prosthesis according to claim 1 wherein the coiled stent graft has an average stent graft diameter to turns-width ratio from about 0.8 to 1 to about 2.4 to 1 when in the radially expanded condition.

3. The endoluminal prosthesis according to claim 1 wherein said stent graft comprises a radiopaque marker.

4. The endoluminal prosthesis according to claim 1 wherein the first edge of one turn lies adjacent to the second edge of an adjacent turn when in the radially expanded condition.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2007
From: THE WALLACE ENTERPRISES, INC.
To: LEMAITRE VASCULAR, INC.
Reel/Frame 020218/0496 →
RELEASE OF SECURITY INTEREST Recorded Dec 5, 2007
From: FIFTH THIRD BANK, NATIONAL ASSOCIATION
To: THE WALLACE ENTERPRISES, INC.
Reel/Frame 020196/0382 →
SECURITY AGREEMENT Recorded Mar 2, 2006
From: THE WALLACE ENTERPRISES, INC.
To: FIFTH THIRD BANK, NATIONAL ASSOCIATION
Reel/Frame 017240/0338 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2006
From: VASCULAR ARCHITECTS, INC.; VENTURE LENDING & LEASING IV, INC.
To: THE WALLACE ENTERPRISES, INC.
Reel/Frame 017176/0112 →
RECORD THE ASSIGNMENT OF PARENT APPLICATION (09/608,281) IN THE CONTINUATION APPLICATION (10/308,574) Recorded Feb 6, 2006
From: KLUMB, KATHERINE J.; FOGARTY, THOMAS J.; KAMDAR, KIRTI P.; HILL, BRADLEY B.
To: VASCULAR ARCHITECTS, INC.
Reel/Frame 017128/0029 →
SECURITY AGREEMENT Recorded Jun 20, 2005
From: VASCULAR ARCHITECTS, INC.
To: DOMAIN PARTNERS V., L.P.; DP V ASSOCIATES, L.P.; ARCH VENTURE FUND IV, L.P.; ARCH ENTREPRENEURS FUND, L.P.; JOHNSON & JOHNSON DEVELOPMENT CORPORATION; VERTICAL FUND I, L.P.; VERTICAL FUND II, L.P.; FOUNDATION MEDICAL PARTNERS, L.P.; EDWARDS LIFESCIENCES CORPORATION; FOGARTY HOLDINGS, L.L.C.; ATHERTON VENTURE FUND II, LLC; FOGARTY, THOMAS J.
Reel/Frame 016199/0632 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2005
From: VASCULAR ARCHITECTS, INC.
To: VENTURE LENDING & LEASING IV, INC.
Reel/Frame 016135/0597 →